Importantly, we further demonstrated that i.c.v. injections of infliximab rescued glucose tolerance in APP/PS1 mice, establishing that brain inflammation triggers alterations in peripheral glucose homeostasis in AβO-injected mice and in the APP/PS1 mouse model of AD. The gene discussed is ABO; the disease is Alzheimer disease.